Li Xiayin, deputy director of the Hong Kong Medical and Health Bureau, revealed when introducing the Hong Kong Genome Program in the Legislative Council that officials are discussing the family members of some patients with genetic diseases in the future.
According to the Hong Kong government communiqué, Li Xiayin introduced the latest situation and future development direction of the Hong Kong Genome Plan at the meeting of the Health Affairs Committee of the Legislative Council on Friday (May 10).
Li Xiayin said that the Hong Kong Government has announced the implementation of the Hong Kong Genome Plan before the 2018 policy report, reserving a total of six years from 2024 to 25 years.The Hong Kong Genome Center, wholly -owned Hong Kong Government, was established in 2020 and was fully operated in 2021.
Li Xiayin pointed out that as of April 15 this year, the plan to recruit 28,473 participants, involving 18,724 families, and successfully allowed some patients who had been seek medical treatment for several years or even decades to get it.Diagnosis, appropriate treatment.For the condition that failed to be diagnosed, the success rate of the pathogenic gene was 28%planned to find the pathogenic gene, and about 25%of similar projects in the world were high.
According to Sing Tao Daily, Li Xiayin revealed that the Hong Kong genome center is currently sorting all the genes of the human body, while some technologies only check for obviously mutations. For exampleFor mutation, general public hospitals have related services to review.The official will formulate some policies next. If some patients suffer from these genetic cancer, their families may be screened first.
